Simultaneous determination of serum galectin-3 and -4 levels detects metastases in colorectal cancer patients

What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries

(2011) P D Sasieni et al.   BRITISH JOURNAL OF CANCER

Galectin-3 – A jack-of-all-trades in cancer

(2011) Anna U. Newlaczyl et al.   CANCER LETTERS

Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium

(2011) H. Barrow et al.   CLINICAL CANCER RESEARCH

The role of galectins in colorectal cancer progression

(2011) Hannah Barrow et al.   INTERNATIONAL JOURNAL OF CANCER

Novel Interaction of MUC4 and Galectin: Potential Pathobiological Implications for Metastasis in Lethal Pancreatic Cancer

(2010) S. Senapati et al.   CLINICAL CANCER RESEARCH

Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis

(2010) Qicheng Zhao et al.   Molecular Cancer

Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis

(2010) Lu-Gang Yu   World Journal of Gastrointestinal Oncology

Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface

(2009) Q. Zhao et al.   CANCER RESEARCH

Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients

(2009) Pierre Vereecken et al.   MELANOMA RESEARCH

Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease

(2008) Sven Saussez et al.   THYROID

The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy

(2007) Sven Saussez et al.   ORAL ONCOLOGY